- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02239068
CT Residual Gastric Fluid Volume
January 16, 2024 updated by: Children's Hospital Medical Center, Cincinnati
Residual Gastric Fluid With Administering Clear Liquids Within Two Hours of Anesthesia in Children
Hypothesis: The investigators hypothesize that more than 50% of the patients receiving enteric contrast material (ECM) < 2 hours of anesthesia/sedation would have residual gastric fluid volume (GFV) > 0.4 ml/kg.
The investigators also hypothesize that measuring GFV by using region of interest in the CT technique is accurate compared to blind aspiration of the gastric contents with a syringe and a multi-orificed orogastric tube.
Study Overview
Status
Completed
Detailed Description
The purpose of our study is to examine the residual gastric fluid volume when oral contrast is administered within 2 hours of anesthesia /sedation and to validate the accuracy of measuring the residual gastric volume by using region of interest in the CT image by using blind aspiration of the gastric contents with a syringe and a multi-orificed orogastric tube.
Study Type
Observational
Enrollment (Actual)
76
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Cincinnati, Ohio, United States, 45229
- Cincinnati Children's Hospital Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 month to 10 years (Child)
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Participants will be recruited from the Radiology CT schedule.
Description
Inclusion Criteria:
- Patients scheduled for CT abdomen with contrast and require anesthesia/sedation
- Subjects must be 1 month to 10 years of age (inclusive)
- The subject's legally authorized representative has given written informed consent to participate in the study
Exclusion Criteria:
- Subjects violate the institution fasting guideline before anesthesia /sedation with the exception of the oral contrast
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Residual gastric fluid volume (GFV) < 0.4ml/kg or > 0.4 ml/kg
Time Frame: Approximately 2 hours
|
Patients will have gastric volume suctioned and measured after the CT scan.
The investigator will compare the amount suctioned to the measurement from the actual CT scan when all patients have been enrolled in the study.
|
Approximately 2 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Residual gastric fluid volume (GFV) < 0.8 ml/kg or > 0.8 ml/kg
Time Frame: Approximate 2 hours
|
Patients will have gastric volume suctioned and measured after the CT scan.
The investigator will compare the amount suctioned to the measurement from the actual CT scan when all patients have been enrolled in the study.
|
Approximate 2 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Mohamed Mahmoud, MD, Children's Hospital Medical Center, Cincinnati
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 28, 2011
Primary Completion (Actual)
June 1, 2023
Study Completion (Actual)
June 1, 2023
Study Registration Dates
First Submitted
July 22, 2014
First Submitted That Met QC Criteria
September 10, 2014
First Posted (Estimated)
September 12, 2014
Study Record Updates
Last Update Posted (Estimated)
January 18, 2024
Last Update Submitted That Met QC Criteria
January 16, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2011-0286
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Clinical CT Abdomen/Pelvic With Oral Contrast and Sedation
-
Duke UniversityNemoto Kyorindo Co, Ltd.TerminatedCT of the Abdomen and Pelvis With Contrast MaterialUnited States
-
Bracco Diagnostics, IncCompletedPatients Requiring Abdominopelvic CT With Oral Administration of ContrastUnited States
-
Hartford HospitalUnknownRoutine Outpatients Undergoing Contrast Enhanced CT Scan of the Abdomen and PelvisUnited States